Dr. Charles L. Brooks' lab focuses on using computer simulations to study biological molecules and how they interact, particularly in the context of drug design and cellular processes. By developing advanced theoretical methods, the team aims to better understand how small molecules can affect proteins and other biological systems, which is crucial for biomedical research and drug discovery. Collaborations with experimental labs allow for practical applications and validations of their computational approaches.

Dr. Joshua A Buss's lab at the University of Michigan focuses on understanding how different metal ions in enzymes influence their reactivity and efficiency. By creating synthetic models of enzyme active sites, the research aims to answer why some enzymes are highly specific in their metal requirements, while others can function with a variety of metals. This work could lead to the development of new catalysts for pharmaceutical applications.

Dr. Nicolai Lehnert's lab at the University of Michigan focuses on developing new materials and methods for generating nitric oxide (NO) gas, which has critical medical uses, including treating lung conditions and preventing infections in medical devices. The lab is specifically working on making low-cost electrochemical systems that can produce NO safely and efficiently, even in the presence of oxygen. By optimizing the catalysts and materials used, the lab aims to enhance NO generation for applications in inhalation therapies and intravascular catheters.

Dr. Nils G. Walter's lab at the University of Michigan focuses on understanding how RNA molecules control gene expression through their unique structures and behaviors. By using advanced microscopy techniques, the lab investigates RNA nanomachines, unraveling their roles in regulating transcription and translation in cells. This research has broad implications for biological processes and can lead to discoveries that reshape our understanding of gene regulation.

Dr. Anna K. Mapp's research lab focuses on understanding how certain proteins control the initiation of gene transcription, which is crucial for processes like cell growth and development. They study the interactions between transcriptional activators and coactivators, which can be targeted for new drug development, especially for diseases like cancer and intellectual disabilities. The lab aims to create synthetic molecules that can either enhance or inhibit these protein interactions, potentially leading to innovative therapeutic solutions.